Latest News

August 3, 2023

AACR’s Clinical Cancer Research publishes a review article, “The New NCI Precision Medicine Trials”

August 3, 2023

Researchers identify two new subtypes of HPV-associated head and neck cancers

July 31, 2023

Proceedings of the National Academy of Sciences publishes the discovery of two new subtypes of HPV-associated head and neck cancers

July 26, 2023

Attention medical and research trainees: Applications are now being accepted for the Edith Peterson Mitchell, MD Health Equity Travel Scholarship to attend the Fall 2023 Group Meeting

July 20, 2023

Press Release: ECOG-ACRIN adds a new treatment trial to the ComboMATCH precision medicine initiative

July 20, 2023

Dr. Pamela Kunz on what’s next after the successful E2211 trial for patients with neuroendocrine tumors

July 19, 2023

The Summer 2023 advocacy blog, Considering Clinical Trials, is now available

June 30, 2023

The May/June 2023 News from ECOG-ACRIN blog is now available

June 22, 2023

The ECOG-ACRIN Clinical Research Associates (CRA) Core Committee is seeking candidates


About Us

The ECOG-ACRIN Cancer Research Group is a strong network of nearly 1300 academic and community-based cancer centers and hospitals in the United States and around the world. We design and conduct biomarker-driven research involving adults who have or are at risk of developing cancer. Learn More


Home

Scientific Pursuits

We are dedicated to improving life for adults affected by cancer. Through our member sites, we are pursuing a robust clinical and translational research portfolio that focuses on precision oncology, immunotherapy, reducing over-treatment and over-diagnosis, leveraging novel biomarker platforms to inform therapeutic decision-making, and advancing standards of care in broad populations of cancer patients and those at risk. Learn More


ECOG-ACRIN by the Numbers

Home
41

Active Clinical Trials

Home
1400

Participating Institutions

Home
67

International Sites

Home
21000

Individual Members


Scientifically rigorous, broadly multidisciplinary, organizationally robust, and internationally respected, the Group is a vibrant component of the National Cancer Institute (NCI) National Clinical Trials Network (NCTN). In addition, we are a Research Base in the NCI Community Oncology Research Program (NCORP).

ECOG-ACRIN Cancer Research Group